Author Archives: Gastroenterology Journal
AGA Technical Review on Coagulation in Cirrhosis
The coagulation system of healthy individuals has evolved to maintain a secure balance of pro- and antihemostatic systems. This fine-tuned balance promotes rapid coagulation during vessel breach, yet simultaneously preserves local control of thrombosis… Continue reading
An enhancer-driven stem cell-like program mediated by SOX9 blocks intestinal differentiation in colorectal cancer
Genomic alterations that encourage stem cell activity and hinder proper maturation are central to the development of colorectal cancer (CRC). Key molecular mediators that promote these malignant properties require further elucidation to galvanize trans… Continue reading
AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis
Cirrhosis is a disease state that is accompanied by significant alterations in laboratory parameters, such as platelet count (PLT) and prothrombin time/international normalized ratio (PT/INR), routinely used to estimate clotting. Based on this measured… Continue reading
Selected Summary An intestine-derived HDL as a novel regulator of the activity of gut-derived LPS: Ushering in a new era of research on the gut-liver axis
Ultra-processed foods and the risk of IBD: is it time to modify diet?
Intake of specific dietary macro- and micronutrients has been implicated in modulating the risk of inflammatory bowel disease (IBD)(Nat Rev Gastroenterol Hepatol 2018;15:525-535). Recent epidemiological and pre-clinical studies have additionally examin… Continue reading
Ongoing Global Impact of the COVID-19 Pandemic on Endoscopy: A Subsequent International Survey of 121 Centers From 35 Countries (BRIEF REPORT)
Out of with the old, in with the new: Replacing the “6-month abstinence rule” with Integrated Care for Alcohol-Associated Liver Disease.
Chemoradiotherapy for T1bN0M0 esophageal squamous cell carcinoma: a practical dilemma delimited by invasion depth
Inclusion of Under-Represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
Find AGA’s NASH Clinical Care Pathway App for iOS and Android mobile devices at nash.gastro.org. Scan this QR code to be taken directly to the website.Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common, currently affecting approxi… Continue reading